News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
685,553 Results
Type
Article (39046)
Company Profile (279)
Press Release (646228)
Section
Business (203866)
Career Advice (1990)
Deals (35362)
Drug Delivery (85)
Drug Development (80799)
Employer Resources (168)
FDA (16086)
Job Trends (14804)
News (344543)
Policy (32436)
Tag
Academia (2530)
Alliances (49086)
Alzheimer's disease (1228)
Approvals (16018)
Artificial intelligence (130)
Bankruptcy (352)
Best Places to Work (11534)
Biotechnology (200)
Breast cancer (120)
Cancer (1081)
Cardiovascular disease (97)
Career advice (1660)
Cell therapy (232)
Clinical research (64238)
Collaboration (387)
Compensation (197)
COVID-19 (2530)
C-suite (94)
Data (1119)
Diabetes (152)
Diagnostics (6138)
Earnings (84817)
Employer resources (146)
Events (109468)
Executive appointments (308)
FDA (16619)
Funding (349)
Gene therapy (177)
GLP-1 (575)
Government (4324)
Healthcare (18668)
Infectious disease (2615)
Inflammatory bowel disease (106)
Interviews (308)
IPO (16297)
Job creations (3623)
Job search strategy (1417)
Layoffs (412)
Legal (7853)
Lung cancer (170)
Manufacturing (176)
Medical device (13174)
Medtech (13179)
Mergers & acquisitions (19140)
Metabolic disorders (401)
Neuroscience (1503)
NextGen Class of 2024 (6499)
Non-profit (4464)
Northern California (1476)
Obesity (231)
Opinion (179)
Patents (102)
People (56266)
Phase I (19950)
Phase II (28298)
Phase III (21095)
Pipeline (455)
Postmarket research (2553)
Preclinical (8491)
Radiopharmaceuticals (236)
Rare diseases (218)
Real estate (5891)
Regulatory (21517)
Research institute (2308)
Resumes & cover letters (349)
Southern California (1298)
Startups (3562)
United States (13432)
Vaccines (548)
Weight loss (167)
Date
Today (119)
Last 7 days (820)
Last 30 days (3799)
Last 365 days (35618)
2024 (32658)
2023 (40074)
2022 (51173)
2021 (55712)
2020 (54087)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31482)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (192)
Asia (37118)
Australia (6057)
California (3315)
Canada (1286)
China (247)
Colorado (144)
Connecticut (152)
Europe (79499)
Florida (458)
Georgia (116)
Illinois (340)
Indiana (196)
Kansas (96)
Maryland (575)
Massachusetts (2601)
Michigan (157)
Minnesota (272)
New Jersey (950)
New York (955)
North Carolina (700)
Northern California (1476)
Ohio (139)
Pennsylvania (842)
South America (1091)
Southern California (1298)
Texas (461)
Utah (90)
Washington State (359)
685,553 Results for "predicine inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
UPDATE: Predicine Introduces PredicineCARE™ NGS Kit for Tumor Profiling
Predicine, Inc., a leading molecular insights company, announced the release of its innovative PredicineCARE™ NGS Kit.
April 11, 2024
·
2 min read
Biotech Bay
Predicine Introduces PredicineCARE™ NGS Kit for Global Clinical Trials, CDx Development and Patient Testing
Predicine, Inc., a leading molecular insights company, announced the release of its innovative PredicineCARE™ NGS Kit.
April 5, 2024
·
2 min read
Business
Predicine Announces Collaboration with Apollomics to Develop PredicineCARE™ as a Companion Diagnostic Assay in Lung Cancer
Predicine, Inc., a leading molecular insights company, announced a collaboration with Apollomics, Inc.
April 5, 2024
·
2 min read
Biotech Bay
Predicine to Present 15 Liquid Biopsy Studies at AACR 2024
Predicine, Inc. A leading precision oncology company, announced that it will present data from 15 ctDNA studies at AACR 2024, spotlighting the clinical utility of Predicine’s genomic and epigenomic liquid biopsy solutions for patient selection, disease monitoring, and disease mechanism studies.
April 5, 2024
·
3 min read
Business
Predicine Announces Collaboration with Janssen to Develop PredicineCARE™ as a Companion Diagnostic Assay in Localized Bladder Cancer
Predicine, Inc., a leading molecular insights company, announced a collaboration with Janssen Pharmaceutica NV, a Johnson & Johnson company.
January 8, 2024
·
2 min read
Biotech Bay
Predicine announces six studies showcasing MRD and liquid biopsy innovations at ESMO 2023
Predicine, a pioneer in the liquid biopsy, announce its participation in the European Society for Medical Oncology (ESMO) 2023 Congress in Madrid, Spain.
October 17, 2023
·
2 min read
Biotech Bay
Predicine to Introduce PredicineALERT™ MRD Assay and Present Twelve Posters at AACR 2023 Conference
Predicine, a global molecular insights company, announced that it will present data from 12 studies and introduce PredicineALERT™, a next-generation Minimal Residual Disease liquid biopsy assay at the 2023 AACR Conference on April 14-19, 2023.
April 14, 2023
·
3 min read
Drug Development
Predicine Announces New Study Published in The New England Journal of Medicine Demonstrating Clinical Utility of its MRD Liquid Biopsy Assay in Supporting Genentech’s Phase 1 Clinical Trial of Divarasib
Predicine, Inc., a pioneer in the field of liquid biopsy, announced a new study published in The New England Journal of Medicine, demonstrating the clinical utility of its minimal residual disease Liquid Biopsy Assay in support of Genentech’s Phase 1 Clinical Trial of Divarasib.
September 20, 2023
·
3 min read
Biotech Bay
Predicine to Present Four Studies at 2023 ASCO Genitourinary (GU) Symposium Highlighting the Technical and Clinical Utility of Predicine’s Liquid Biopsy Based Assays
Predicine, a global molecular insights company, is committed to advancing genitourinary cancer detection and treatment decisions through its proprietary non-invasive next-generation sequencing assays.
February 16, 2023
·
2 min read
Biotech Bay
Predicine to Introduce PredicineALERT™ MRD Assay and Present Two ctDNA Studies in Genitourinary Cancers at AUA 2023 Annual Meeting
Predicine announced that it will present two studies and introduce PredicineALERT™ Minimal Residual Disease liquid biopsy assay to genitourinary cancers at the 2023 American Urological Association Annual Meeting held in Chicago between April 28 to May 1, 2023.
April 28, 2023
·
2 min read
1 of 68,556
Next
